Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | LDHA | P00338 | 2/20 | 0.50 |
| ▸ | LDHB | P07195 | 1/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.42 |
| ▸ | OR51E2 | Q9H255 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.36 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL27515310 | 1.00 | CA1 (0.57) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL11211823 | 1.00 | CA1 (0.57) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL29505271 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL11805656 | 1.00 | CA1 (0.57) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL736262 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL11213178 | 1.00 | CA1 (0.57) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL28622815 | 1.00 | CA1 (0.57) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL11805219 | 1.00 | CA1 (0.57) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL776 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL8432824 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111563-A1 | MILK PEPTIDE COMPOSITIONS FOR PHARMACEUTICAL AND COSMECEUTICAL USE | MATRUBIALS INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-118084055-A | Sodium chromite material and preparation method and application thereof | 广东邦普循环科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118026223-A | Method for preparing high-purity lithium fluoride by using lithium hydroxide circulating mother liquor | 江西云威新材料股份有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-113813406-B | Nano-particles for treating atherosclerosis by MRI and chemical excitation photodynamic therapy | 南京鼓楼医院 | 2023-03-24 | — | — | CN | claimed |
| CN-113577292-B | Tumor combined treatment preparation with cell exosome loaded with stimulating reagent and photosensitizer and application thereof | 深圳市第二人民医院(深圳市转化医学研究院) | 2022-10-18 | — | — | CN | claimed |
| CN-115043840-A | Methods for preparing TOLL-like receptor modulators | 吉利德科学公司 | 2022-09-13 | — | — | CN | claimed |
| CN-114558242-A | Soluble microneedle and manufacturing method thereof | 优微（珠海）生物科技有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-111909150-B | Near-infrared fluorescent dye and application thereof in preparation of chemical near-infrared radiant agent | 北京文海阳工贸有限责任公司 | 2022-05-10 | — | — | CN | claimed |
| CN-110488688-B | Intelligent trolley advancing method and system based on fluorescence reaction and photosensitive sensor | 华南理工大学 | 2022-03-29 | — | — | CN | claimed |
| CN-113813406-A | Nano-particles for treating atherosclerosis by MRI and chemical excitation photodynamic therapy | 南京鼓楼医院 | 2021-12-21 | — | — | CN | claimed |
| CN-111909150-A | Near-infrared fluorescent dye and application thereof in preparation of chemical near-infrared radiant agent | 北京文海阳工贸有限责任公司 | 2020-11-10 | — | — | CN | claimed |
| CN-111815907-A | Landslide multistage monitoring and early warning device and application method thereof | 合肥工业大学 | 2020-10-23 | — | — | CN | claimed |
| EP-3194402-B1 | METHODS OF PREPARING TOLL-LIKE RECEPTOR MODULATORS | GILEAD SCIENCES INC (US) | 2018-11-21 | — | — | EP | claimed |
| EP-3194402-A1 | METHODS OF PREPARING TOLL-LIKE RECEPTOR MODULATORS | Gilead Sciences, Inc. (US) | 2017-07-26 | — | — | EP | claimed |
| US-9573952-B2 | Methods of preparing toll-like receptor modulators | GILEAD SCIENCES, INC. (US) | 2017-02-21 | — | — | US | claimed |
| WO-2016044183-A1 | METHODS OF PREPARING TOLL-LIKE RECEPTOR MODULATORS | GILEAD SCIENCES, INC. (US) | 2016-03-24 | — | — | WO | claimed |
| US-20160075707-A1 | METHODS OF PREPARING TOLL-LIKE RECEPTOR MODULATORS | GILEAD SCIENCES, INC. | 2016-03-17 | — | — | US | claimed |
| WO-2014093583-A2 | SYNTHETIC METHODS FOR PREPARING 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE MONO HYDROCHLORIDE, OTHER SALT FORMS OF THIS COMPOUND AND INTERMEDIATES THEREOF | ARIAD PHARMACEUTICALS, INC. (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2004089357-A2 | ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-10-21 | — | — | WO | claimed |
| US-4238195-A | Fluorescer-labeled specific binding assays | MILES LABORATORIES, INC. (US) | 1980-12-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075707-A1 | METHODS OF PREPARING TOLL-LIKE RECEPTOR MODULATORS | TLR3, TLR4, TLR6 | CA1 4520/4885CA2 3893/4885CA9 4294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.